glp 1 and pancreatitis New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events The occasional acute episode of
Description
While previous generations GLP-1 agonists (liraglutide) have led to weight loss of 5-10% in most cases, semaglutide can lead to weight loss of up to 20%
Non-alcohol substance use disorder after bariatric surgery in the prospective, controlled Swedish Obese Subjects study
Together they established that the GLP-1 (7-37) synthesised by Mojsov encouraged the secretion of insulin in rat pancreatic islet cells
The other three DPP-4 inhibitors, teneligliptin, anagliptin and trelagliptin, are only approved in the Japanese and Korean markets
Supplementary Information The online version contains supplementary material available at 10.1007/s13300-025-01804-w
